Huake Run (Zhejiang) Biotechnology Co., Ltd. was founded in 2011 and is located in the Hangzhou Bay New Area—a cutting-edge industrial city situated at the geometric center of Shanghai, Hangzhou, and Ningbo. Since its inception, Huake Run has assembled a distinguished team of senior executives from Fortune Global 500 companies and leading domestic and international publicly listed enterprises, as well as top-tier R&D professionals in the medical device field. Through continuous innovation and integration, the company is committed to establishing itself as a pioneering enterprise on the digital orthopedic minimally invasive platform powered by robotics.

Huake Run is the first manufacturer in China to obtain both domestic and EU approvals for its angled vertebral augmentation device, and it offers the most comprehensive portfolio of surgical instruments for both angled and conventional vertebral augmentation procedures. As a global leader in angled vertebral augmentation technology, the company is also the preferred supplier of high-quality vertebral augmentation devices for clinicians. In addition, Huake Run boasts a full range of vertebral augmentation products, along with innovative offerings in spinal implants, sports medicine, orthopedic active devices and consumables, and artificial intelligence. To date, the company has filed 223 domestic patent applications, including 90 invention patents, 121 utility model patents, and 11 design patents; it has also filed 18 international patent applications, of which 9 have been granted. The company currently holds 27 Class I, 30 Class II, and 18 Class III NMPA medical device registration certificates, as well as 12 CE certifications and 12 U.S./FDA approvals, with an anticipated annual average of at least five new certifications going forward. In 2021, Huake Run invested over RMB 100 million in the European innovation robotics firm Interventional Systems (INS) and established a joint venture in Shanghai—Sino-European Zhiwei (Shanghai) Robotics Co., Ltd.—marking a pivotal milestone in Huake Run’s expansion into the digital orthopedics and surgical robotics markets. To date, Sino-European Zhiwei has filed 23 domestic patent applications, including 11 inventions, 7 utility models, and 5 designs.

Huake Run is a high-tech enterprise that has been repeatedly recognized as a star-rated labor-management enterprise and has received honors such as “Outstanding Enterprise in Zhejiang Province’s Health Industry” and “Outstanding Enterprise in the Ningbo Regional Competition of the China Innovation and Entrepreneurship Contest.” In various innovation competitions, Huake Run has consistently won prestigious awards, including the Best Innovative Orthopedic Device Award at the 2017 World Congress of Orthopaedic Innovation, the Second Prize in the Ningbo Regional Competition of the China Innovation and Entrepreneurship Contest, and the Award for Outstanding Enterprise Technological Innovation Team in the Ningbo Hangzhou Bay New Area. Its superior management capabilities and outstanding innovative strength serve as the solid foundation and inexhaustible driving force behind Huake Run’s rapid development and sustained progress.

Guided by the vision of “Kerun China, Leading the Future,” we are committed to innovating minimally invasive orthopedic techniques, delivering superior minimally invasive surgical solutions to patients and physicians alike. In the fields of consumables and medical devices, we strive to become the most innovative company in the minimally invasive orthopedics sector.